Results 101 to 110 of about 624,402 (215)

Thymic Carcinoma: Current Staging Does Not Predict Prognosis [PDF]

open access: yes, 1998
Background: Thymic carcinomas are currently staged by Masaoka classification, a staging system for thymomas. We retrospectively evaluated surgical patients with thymic carcinoma to determine prognostic factors and to evaluate the usefulness of Masaoka ...
Ginsberg, Robert J.   +6 more
core   +1 more source

circMAN1A2 as an Isoform‐Resolved Circular RNA Hub in Cancer

open access: yesCancer Science, Volume 117, Issue 9, Page 2345-2356, September 2026.
circMAN1A2 as an isoform‐resolved circular RNA hub in cancer. circMAN1A2 is generated by back‐splicing of MAN1A2 pre‐mRNA, with alternative circularization producing multiple isoforms, including the predominant circMAN1A2(2–5). Its mechanistic interfaces include miRNA‐associated regulation, RBP binding/proteostasis control, BSJ‐mediated RNA–RNA pairing,
Hanyu Shang   +4 more
wiley   +1 more source

Breast Metastasis of Thymic Carcinoma

open access: yes, 2014
Aims: To enforce the concept that the breast is a possible site of metastases from other organs. Presentation: We describe a case of a 70 year old woman diagnosed with thymic carcinoma which developed, ten months after, a single breast nodular lesion ...
CARBONETTI, FRANCESCO   +9 more
core   +1 more source

Age‐ and gender‐specific disease distribution and the diagnostic accuracy of CT for resected anterior mediastinal lesions

open access: yesThoracic Cancer, 2019
Background Anterior mediastinal lesions account for approximately half of all mediastinal masses and computed tomography (CT) is known to exhibit limited differentiating performance.
Ju Gang Nam   +5 more
doaj   +1 more source

Novel biomarkers for thymic carcinoma

open access: yes, 2019
Thymic carcinoma (TC), the rarer among Thymic Epithelial Tumors (TET), occur with an incidence rate of 0.2-0.5/million/yr. Difficulties in the evaluation of molecular aspects derive from the extreme rarity of these tumors.
Casini, B.   +9 more
core   +1 more source

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive [PDF]

open access: yes, 2014
Although historically thymoma and thymic carcinoma have been treated surgically, radiation therapy also has an important role, either as postoperative therapy to reduce the risk of mediastinal recurrence or as part of definitive treatment for patients ...
Ritsuko Komaki   +3 more
core   +1 more source

Paraneoplastic dermatomyositis as presentation of thymic carcinoma

open access: yes, 2013
Thymic carcinomas are very rare and heterogeneous groups of anterior mediastinum neoformations with an extremely aggressive behavior. Often, the diagnosis is made in the advanced stages.
Andrea Dell’Amore   +11 more
core   +1 more source

Thymic Carcinoma in a Patient with Melanoma

open access: yesIndian Journal of Dermatology, 2022
Hiroyuki Goto   +6 more
openaire   +3 more sources

Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case

open access: yesThe Pan African Medical Journal, 2019
Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment.
Agustín Buero   +3 more
doaj   +1 more source

A Rare Tumor with a Very Rare Initial Presentation: Thymic Carcinoma as Bone Marrow Metastasis

open access: yesCase Reports in Pathology, 2017
Tumors of thymus gland are rare and account for 0.2% to 1.5% of all the neoplasms. They constitute a heterogeneous group that has an unknown etiology and a complex as well as varied biology. This has led to difficulty in their histological classification
Sonam Sharma, Leelavathi Dawson
doaj   +1 more source

Home - About - Disclaimer - Privacy